Elobixibat hydrate: IBAT Research Workflows
2026-08-14
Elobixibat hydrate enables controlled studies of bile acid redistribution, intestinal motility, and gut–metabolic signaling. This workflow-focused guide shows how to connect selective IBAT inhibition with secretion, GLP-1, bowel-preparation, and translational assay endpoints while avoiding common solubility and interpretation errors.
Ibotenic Acid in Pain-Circuit Research
2026-08-13
Ibotenic acid is a high-purity NMDA receptor agonist for controlled perturbation of glutamatergic circuits, from focal lesion studies to neurodegenerative disease models. This guide connects formulation control, pain-circuit mapping, assay design, and troubleshooting for more reproducible neuroscience workflows.
SCH772984 HCl: Reliable ERK Assay Design
2026-08-13
This scenario-based guide explains how SCH772984 HCl, SKU B5866, can improve ERK1/2 inhibition studies involving cell viability, proliferation, and cytotoxicity assays. It covers assay design, stock preparation, data interpretation, and practical vendor-selection criteria using documented potency, solubility, and storage information.
Cytarabine Beyond DNA Damage: A Translational Lens
2026-08-12
Cytarabine and AraC are more than DNA synthesis perturbagens: they are strategic tools for connecting nucleotide metabolism, p53-linked apoptosis, resistance biology, and regulated cell-death research. This thought-leadership framework shows how to use AraC rigorously in leukemia models while borrowing carefully from viral necroptosis research without overstating mechanistic convergence.
Nelfinavir Mesylate: HIV and Ferroptosis Workflows
2026-08-12
Nelfinavir Mesylate supports precise HIV-1 protease inhibition assays while offering a research bridge into DDI2-NFE2L1-ubiquitin-proteasome signaling and ferroptosis sensitivity. This workflow-focused guide covers concentration planning, orthogonal readouts, controls, and troubleshooting for virology and cell-death studies.
TCEP Hydrochloride for Protein Assay Workflows
2026-08-11
TCEP hydrochloride delivers odorless, water-soluble disulfide reduction for protein preparation, redox assays, digestion, and structural mass spectrometry. This guide translates its chemistry into executable workflows and shows how reduction control can support, but should not be confused with, capture-and-release sensitivity strategies in lateral flow assays.
NFIA in Bone Homeostasis: Formation and Resorption
2026-08-10
Dong and colleagues identify nuclear factor I/A (NFIA) as a previously unrecognized regulator of bone homeostasis that coordinates osteoclast and osteoblast differentiation from mesenchymal stem/progenitor cells. Their conditional knockout and mechanistic analyses show that NFIA restrains bone resorption through RANKL repression, while also limiting osteoblastogenesis through SFRP1-mediated inhibition of Wnt/β-catenin signaling; the resorptive phenotype dominates when NFIA is lost.
EGTA: From Calcium Chelation to Assay Design
2026-08-09
EGTA (egtazic acid) is more than a calcium chelator: it is a tool for separating extracellular calcium dependence from channel-specific signaling. This guide translates cardiac vagal neuron physiology into rigorous assay design for calcium signaling, neuroprotection, and apoptosis research.
2,2,2-Trichloroethanol: Assay Design Guide
2026-08-08
2,2,2-Trichloroethanol is a versatile small molecule biochemical reagent for protein-focused workflows. This guide explains how to use its chemical properties responsibly while translating dopamine-neuron imaging findings into better orthogonal assay decisions.
GLT-1 Upregulation Counters TBI via CB1-CREB
2026-08-07
A 2025 Biomolecules study identifies a mechanistic connection between elevated 2-AG, CB1 activation, reduced astrocytic GLT-1, and glutamate-related neuronal injury after traumatic brain injury. Using pharmacological manipulation and behavioral, histological, and molecular assays, the authors show that AM 281-associated CB1 blockade can preserve GLT-1, reduce neuronal apoptosis, and improve cognitive performance in mice.
G418 Sulfate (Geneticin): Precision Selection & Antiviral As
2026-08-07
Geneticin, G-418 Sulfate stands out for dual applications: robust genetic engineering selection and potent inhibition of Dengue virus serotype 2. This guide delivers protocol optimizations, cross-domain insights, and troubleshooting strategies to harness the highest fidelity from APExBIO’s ultra-pure G418.
Dihydroethidium in Translational Redox Biology: Mechanisms &
2026-08-06
Explore how Dihydroethidium (DHE, hydroethidine) transforms superoxide detection in live-cell models, bridging mechanistic insight with strategic guidance for translational research. This article integrates new findings on SERCA2 dysfunction-driven oxidative stress, delivers actionable protocol parameters, and positions DHE as an essential tool for advancing cardiovascular and inflammation studies—going beyond standard product literature.
YM 58483 (BTP2) in Advanced SOCE Blockade and Fibrosis Model
2026-08-06
YM 58483 (BTP2) is redefining calcium signaling research with its selective SOCE inhibition, enabling precise dissection of immune and fibrotic mechanisms. Leveraging the latest findings on the ORAI2/JNK/NFAT1 axis, this article details how to integrate YM 58483 into robust experimental workflows for T cell and fibrosis models, with actionable troubleshooting and optimization tips.
LNP-Delivered Circular IL-23 mRNA and MSA-2-Pt Synergy in Tu
2026-08-05
The referenced study demonstrates that combining lipid nanoparticle (LNP)-delivered circular IL-23 mRNA with a platinum-modified STING agonist (MSA-2-Pt) markedly enhances antitumor immunity and prolongs survival in a melanoma model. This work highlights the therapeutic promise of integrating mRNA delivery systems with next-generation immunomodulators for targeted cancer therapy.
Targeting Pancreatic Fibrosis: MFGE8-ANXA1-SMAD2/3 Pathway I
2026-08-05
This study demonstrates that umbilical cord-derived mesenchymal stem cell extracellular vesicles (UCMSC-EVs) alleviate pancreatic fibrosis by modulating the MFGE8-dependent ANXA1-SMAD2/3 axis in a chronic pancreatitis murine model. By developing a novel rhMFGE8 nanoparticle platform, the research offers mechanistic clarity and translational benchmarks for antifibrotic therapy development.
466 records 9/32 page Previous Next First page 上5页 678910 下5页 Last page